NEPHROS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
NEPHROS, INC. (NEPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 221.30 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-12
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-12-31 was 1.22M shares.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-09-30 was 90.00K shares.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-06-30 was 418.71K shares.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-03-31 was 579.57K shares.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 221.30K shares, a 153.79% increase from fiscal 2024.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 87.20K shares, a 85.05% decline from fiscal 2023.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 583.09K shares, a 108.91% increase from fiscal 2022.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 279.12K shares, a 28.64% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 221.30K shares 10-K · filed 2026-03-12 | |||||
| 2024-12-31 | 87.20K shares 10-K · filed 2025-03-24 | |||||
| 2023-12-31 | 583.09K shares 10-K · filed 2024-03-15 | |||||
| 2022-12-31 | 279.12K shares 10-K · filed 2024-03-15 | |||||
| 2021-12-31 | 391.16K shares 10-K · filed 2023-03-23 | |||||
| 2020-12-31 | 291.65K shares 10-K · filed 2022-03-03 | |||||
| 2019-12-31 | 218.29K shares 10-K · filed 2021-03-01 | |||||
| 2018-12-31 | 126.95K shares 10-K · filed 2020-02-27 | 1.14M shares 10-K · filed 2019-03-12 | ||||
| 2017-12-31 | 1.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 1.31M shares derived: sum of 2 quarters · filed 2019-03-12 | 1.73M shares derived: sum of 3 quarters · filed 2019-03-12 | 2.31M shares 10-K · filed 2019-03-12 | ||
| 2017-09-30 | 90.00K shares 10-Q · filed 2017-11-09 | 508.71K shares derived: sum of 2 quarters · filed 2017-11-09 | 1.09M shares 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 418.71K shares 10-Q · filed 2017-08-08 | 998.28K shares 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | 579.57K shares 10-Q · filed 2017-05-09 | |||||
| 2016-12-31 | 510.52K shares 10-K · filed 2018-02-26 | |||||
| 2015-12-31 | 414.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-20 | 669.14K shares derived: sum of 2 quarters · filed 2017-03-20 | 2.91M shares 10-K · filed 2017-03-20 | |||
| 2015-09-30 | 254.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 2.50M shares 10-Q · filed 2015-11-10 | ||||
| 2015-09-09 | 195.00K shares 10-Q · filed 2015-11-10 | |||||
| 2015-06-30 | 2.24M shares 10-Q · filed 2015-08-10 | |||||
| 2014-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 50.00K shares derived: sum of 2 quarters · filed 2016-03-30 | 98.86K shares derived: sum of 3 quarters · filed 2016-03-30 | 352.52K shares 10-K · filed 2016-03-30 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 48.86K shares derived: sum of 2 quarters · filed 2014-11-13 | 302.52K shares 10-Q · filed 2014-11-13 | 362.96K shares derived: sum of 4 quarters · filed 2015-04-15 | ||
| 2014-06-30 | 48.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | 302.52K shares 10-Q · filed 2014-08-14 | 362.96K shares derived: sum of 3 quarters · filed 2015-04-15 | 362.96K shares derived: sum of 4 quarters · filed 2015-04-15 | ||
| 2014-03-31 | 253.66K shares 10-Q · filed 2014-05-14 | 314.10K shares derived: sum of 2 quarters · filed 2015-04-15 | 314.10K shares derived: sum of 3 quarters · filed 2015-04-15 | 490.97K shares derived: sum of 4 quarters · filed 2015-04-15 | ||
| 2013-12-31 | 60.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | 60.44K shares derived: sum of 2 quarters · filed 2015-04-15 | 237.31K shares derived: sum of 3 quarters · filed 2015-04-15 | 237.31K shares 10-K · filed 2015-04-15 | ||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 176.88K shares derived: sum of 2 quarters · filed 2013-11-14 | 176.88K shares 10-Q · filed 2013-11-14 | 176.88K shares derived: sum of 4 quarters · filed 2014-03-28 | ||
| 2013-06-30 | 176.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | 176.88K shares 10-Q · filed 2013-08-13 | 176.88K shares derived: sum of 3 quarters · filed 2014-03-28 | 508.43K shares derived: sum of 4 quarters · filed 2014-03-28 | ||
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-28 | 331.55K shares derived: sum of 3 quarters · filed 2014-03-28 | |||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | 331.55K shares derived: sum of 2 quarters · filed 2014-03-28 | 1.55M shares 10-K · filed 2014-03-28 | |||
| 2012-09-30 | 331.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 1.55M shares 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | 1.22M shares 10-Q · filed 2012-08-14 | |||||
| 2011-12-31 | 702.50K shares 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |